Global Paediatric Epilepsy Therapeutics Market

Paediatric Epilepsy Therapeutics Comprehensive Study by Application (Hospitals, Neurology Centers, Home Care Settings, Ambulatory Surgical Centers), Disease Type (Benign Rolandic Epilepsy, Childhood Absence Epilepsy, Juvenile Myoclonic Epilepsy, Infantile Spasms, Lennox-Gas taut Syndrome), Route of Administration (Oral, Parenteral), Therapy Type (Anti-Epileptic Drugs, Dietary Supplements, Surgical Therapies, Others)

Paediatric Epilepsy Therapeutics Market by XX Submarkets | Forecast Years 2023-2028

Summary
Market Segments
Table of Content
List of Table & Figures
Players Profiled

What is Paediatric Epilepsy Therapeutics Market?

Epilepsy is a chronic neurological disorder characterized by frequent and recurring seizures leading to unusual behavior It can be considered as spectrum disorder due to varied types of seizures, causes, and different degrees of severity. Epilepsy is a condition in which the brain's function is disrupted due to aberrant or excessive electrical discharges from brain cells. Epilepsy is one of the most common diagnoses seen by pediatric neurologists. When antiepileptic drugs fail to relieve seizures adequately in children and adolescents, more invasive therapies such as epilepsy surgery and an implanted device to stimulate the vague nerve should be considered. Increases in online drug purchases are the trend of market growth.

Highlights from Paediatric Epilepsy Therapeutics Market Study

Attributes	Details
Study Period	2018-2028
Base Year	2022
Unit	Value (USD Million)
Key Companies Profiled	Engrail Therapeutics (California), Cerevel Therapeutics (United States), Xenon Pharmaceuticals Inc. (Canada), Amzell (Germany), Eisai (Japan), GlaxoSmithKline (United Kingdom), GW Pharmaceuticals (United Kingdom), Pfizer (United States), W Pharmaceuticals (Belgium) and Abbott Laboratories (United States)

Paediatric epilepsy Therapeutics is a competitive market due to the presence of a large number of established competitors. The market is highly competitive with a few players occupying the major share. The key players are highly focused on developing and innovating new strategies to maintain their market position and customer base. The companies are also planning strategic activities like partnerships, collaboration, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Paediatric Epilepsy Therapeutics market throughout the forecasted period.

Engrail Therapeutics (California), Cerevel Therapeutics (United States), Xenon Pharmaceuticals Inc. (Canada), Amzell (Germany), Eisai (Japan), GlaxoSmithKline (United Kingdom), GW Pharmaceuticals (United Kingdom), Pfizer (United States), W Pharmaceuticals (Belgium) and Abbott Laboratories (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Jazz Pharmaceuticals (Ireland), Novartis (Switzerland) and UCB (Belgium).

Paediatric Epilepsy Therapeutics Market Segmentation:

Scope	Sub-Segments
Application / End User	Hospitals, Neurology Centers, Home Care Settings and Ambulatory Surgical Centers
Disease Type	Benign Rolandic Epilepsy,Childhood Absence Epilepsy,Juvenile Myoclonic Epilepsy,Infantile Spasms,Lennox-Gas taut Syndrome
Route of Administration	Oral,Parenteral
Therapy Type	Anti-Epileptic Drugs,Dietary Supplements,Surgical Therapies,Others

On the basis of geography, the market of Paediatric Epilepsy Therapeutics has been segmented into . Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:

Growing Funding and Investments for Life Science Research and Increase in online drug purchase

Market Growth Drivers:

Increasing Investment by Governments of Various Countries in the Field Of Life Science and the Healthcare Sector and Increasing no of paediatric Epilepsy Therapeutics patient .

Challenges:

Major side effects such as liver damage associated with pediatric epilepsy therapeutics

Restraints:

Increase in the Amount of Counterfeit Drugs

Opportunities:

Increasing developments in patient care through diagnosis and optimal treatment

Key Target Audience

pharmaceutical companies, Government and private laboratories, Research and Development (R&D) companies, Medical research laboratories, Market research and consulting service providers, Government Agencies, End User Industry and Others

Market Leaders & Development Strategies

In February 2021, The acquisition of the UK heavyweight GW Pharmaceuticals by Jazz Pharmaceuticals has been hailed as a major validation of the medical cannabinoid industryThe deal is the largest to date in the medical cannabinoid field. Jazz�s offer valued GW�s shares nearly 50% higher than their previous day�s close.
In January 2023, Xenon Pharmaceuticals is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy

Market Segments

Report Objectives / Segmentation Covered

By Application

Hospitals
Neurology Centers
Home Care Settings
Ambulatory Surgical Centers

By Disease Type

Benign Rolandic Epilepsy
Childhood Absence Epilepsy
Juvenile Myoclonic Epilepsy
Infantile Spasms
Lennox-Gas taut Syndrome

By Route of Administration

Oral
Parenteral

By Therapy Type

Anti-Epileptic Drugs
Dietary Supplements
Surgical Therapies
Others

By Regions

Table of Content

List of Tables & Figures

List of Tables

Table 1. Paediatric Epilepsy Therapeutics: by Application(USD Million)
Table 2. Paediatric Epilepsy Therapeutics: by Disease Type(USD Million)
Table 3. Paediatric Epilepsy Therapeutics: by Route of Administration(USD Million)
Table 4. Paediatric Epilepsy Therapeutics: by Therapy Type(USD Million)
Table 5. Company Basic Information, Sales Area and Its Competitors
Table 6. Company Basic Information, Sales Area and Its Competitors
Table 7. Company Basic Information, Sales Area and Its Competitors
Table 8. Company Basic Information, Sales Area and Its Competitors
Table 9. Company Basic Information, Sales Area and Its Competitors
Table 10. Company Basic Information, Sales Area and Its Competitors
Table 11. Company Basic Information, Sales Area and Its Competitors
Table 12. Company Basic Information, Sales Area and Its Competitors
Table 13. Company Basic Information, Sales Area and Its Competitors
Table 14. Company Basic Information, Sales Area and Its Competitors
Table 15. Paediatric Epilepsy Therapeutics: by Application(USD Million)
Table 16. Paediatric Epilepsy Therapeutics: by Disease Type(USD Million)
Table 17. Paediatric Epilepsy Therapeutics: by Route of Administration(USD Million)
Table 18. Paediatric Epilepsy Therapeutics: by Therapy Type(USD Million)
Table 19. Research Programs/Design for This Report
Table 20. Key Data Information from Secondary Sources
Table 21. Key Data Information from Primary Sources

List of Figures

Companies Mentioned

List of companies from research coverage that are profiled in the study

Additional players considered in the study are as follows:

Jazz Pharmaceuticals (Ireland) , Novartis (Switzerland) , UCB (Belgium)

Select User Access Type

Single User
$ 3800
Corporate User
$ 7000

Key Highlights of Report

Apr 2023 241 Pages 72 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing

Check Discount Now

Global Paediatric Epilepsy Therapeutics Market Quantitative research analysis

Global Paediatric Epilepsy Therapeutics Market Qualitative Industry Analysis

DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?

"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Which factors would majorly drive the Paediatric Epilepsy Therapeutics Market?

"Increasing Investment by Governments of Various Countries in the Field Of Life Science and the Healthcare Sector " is seen as one of major growth factors of Paediatric Epilepsy Therapeutics Market in years to come.

Can we have customized study for Paediatric Epilepsy Therapeutics Market?

The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.

Why are some known companies left out of the Paediatric Epilepsy Therapeutics Market report?

The Paediatric Epilepsy Therapeutics market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete of companies available in our research coverage.

Know More About Global Paediatric Epilepsy Therapeutics Market Report?

Have a Query? Click Here